Patient presents with an incidentally discovered liver hemangioma, likely during imaging surveillance for (state reason for imaging, e.g., abdominal pain, routine screening).  The patient denies any symptoms specifically attributable to the hemangioma, such as right upper quadrant pain, abdominal fullness, or nausea.  Physical examination reveals no hepatomegaly or palpable abdominal masses.  Liver function tests, including AST, ALT, alkaline phosphatase, and bilirubin, are within normal limits.  Imaging studies (specify modality, e.g., ultrasound, CT scan, MRI) demonstrate a (describe characteristics, e.g., well-defined, hyperechoic, non-contrast enhancing) lesion consistent with a hepatic hemangioma, measuring (size) cm in the (segment) of the liver.  Differential diagnosis includes hepatic adenoma, focal nodular hyperplasia, and hepatocellular carcinoma.  Given the typical imaging characteristics and asymptomatic presentation, the diagnosis of liver hemangioma is favored.  Management plan consists of conservative observation with repeat imaging in (timeframe, e.g., 6-12 months) to assess for any changes in size or characteristics.  Patient education provided regarding the benign nature of hepatic hemangiomas and the low risk of complications.  ICD-10 code D18.0 (Benign neoplasm of liver) is applicable.  The patient understands the plan and agrees to follow-up.